Title : Down regulation of multidrug resistance protein-1 expression in patients with early rheumatoid arthritis exposed to methotrexate as a first disease-modifying antirheumatic drug.

Pub. Date : 2006 Oct

PMID : 16504991






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In patients who were positive for MRP1 at baseline (61%), treatment with MTX and folic acid led to a marked down regulation of MRP1 expression at 6 months. Folic Acid ATP binding cassette subfamily B member 1 Homo sapiens
2 In patients who were positive for MRP1 at baseline (61%), treatment with MTX and folic acid led to a marked down regulation of MRP1 expression at 6 months. Folic Acid ATP binding cassette subfamily B member 1 Homo sapiens
3 CONCLUSION: In patients with rheumatoid arthritis expressing MRP1, treatment with MTX and folic acid led to down regulation of MRP1 expression. Folic Acid ATP binding cassette subfamily B member 1 Homo sapiens
4 CONCLUSION: In patients with rheumatoid arthritis expressing MRP1, treatment with MTX and folic acid led to down regulation of MRP1 expression. Folic Acid ATP binding cassette subfamily B member 1 Homo sapiens